Table 2. Characteristics of studies reporting sensitivity, stratified by dataset type.
First author, year of publication |
Year of study | Country | Study population composition |
Age (years)* |
Proportion male |
Study size (n) | Routine dataset used | Coding system | Codes used to identify cases | Diagnostic coding position | Reference standard |
---|---|---|---|---|---|---|---|---|---|---|---|
Mortality certificate-derived datasets: | |||||||||||
Benito-Leόn 2014[37] |
1994–2007 | Spain | Three communities near Madrid | Mean 77 | 56% | 82 | Mortality | ICD-9 (pre 1999) ICD-10 (post 1999) |
Not specified (investigated PD) | Primary | Screening (in-person, telephone and mail questionnaire) and neurological examination |
Beyer 2001[38] |
1993–1996 | Norway | County (Rogaland) |
Mean 79 | Unclear | 84 | Mortality | ICD-9 or ICPC | Not specified (investigated PD) | Primary + Any | Semi-structured interview and a clinical examination |
Fall 2003[39] |
1989–1998 | Sweden | Central district of Ӧstergӧtland | Mean 82 | Unclear | 121 | Mortality | ICD-9 | Not specified (investigated PD) | Primary + Any | Examination and medical record review |
Feldman 2012[24] |
1998–2008 | Sweden | Twins across Sweden >50yrs | Mean 75 | Unclear | PD: 77 Parkinsonism: 127 |
Mortality | ICD-10 | PD: G20 Parkinsonism: G21.4, G21.8, G21.9, G23.1, G23.2, G23.9, G25.9 |
Any | Screening interview, medical record review and examination |
Williams-Gray 2013[40] |
2000–2012 | UK | County (Cambridgeshire) |
Mean 70 | Unclear | 63 | Mortality | Not specified | Not specified (investigated PD) | Primary + Any | History and neurological examination |
Hospital-derived datasets: | |||||||||||
Feldman 2012[24] |
1964–2009 |
Sweden | Twins across Sweden >50yrs | Mean 75 | Unclear | PD: 132 Parkinsonism: 194 |
Hospital: inpatient | ICD-7 (1961–67) ICD-8 (1968–86) ICD-9 (1987–96) ICD-10 (1997–2009) |
PD: ICD-7: 350; ICD-8: 342.00; ICD-9: 332.0; ICD-10: G20 Parkinsonism: ICD-8: 342.08, 342.09; ICD-9: 333.0; ICD-10: G21.4, G21.8, G21.9, G23.1, G23.2, G23.9, G25.9 |
Any | Screening interview, medical record review and examination |
Year of study: the time period during which coded data was collected.
*—any information given regarding the ages of cases or age at recruitment Study size: the total number of true positive according to the reference standard (true positives and false negatives). Where both PD and parkinsonism were investigated in one article, study sizes for both are displayed. Study population composition: population cohort from which cases were identified.
ICD codes for Parkinson’s disease—ICD-7 350; ICD-8 342.00; ICD-9 332.0; ICD-10 G20.
ICD codes for other Parkinsonism—ICD-8: 342.08 (other defined Parkinsonism), 342.09 (unspecified Parkinsonism); ICD-9: 333.0 (other degenerative diseases of the basal ganglia); ICD-10: G21.4 (vascular Parkinsonism), G21.8 (other defined secondary Parkinsonism), G21.9 (unspecified secondary Parkinsonism), G23.1 (progressive supranuclear ophthalmoplegia), G23.2 (striatonigral degeneration), G23.9 (unspecified degenerative disease of basal ganglia), G25.9 (unspecified extrapyramidal and movement disorder).